Suchergebnisse - "Ramanan, Athimalaipet V."

PubPharm (12)

1

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY) : a randomised, controlled, open-label, platform trial

enthalten in: The Lancet. Child & adolescent health | 2024

von RECOVERY Collaborative Group | Faust, S. | Haynes, R. | +98

2

Baricitinib in juvenile idiopathic arthritis : an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial

enthalten in: Lancet (London, England) | 2023

von Ramanan, A. | Quartier, P. | Okamoto, N. | +105

CommentIn: Lancet. 2023 Aug 12;402(10401):508-509. - PMID 37423229

3

Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation : an exploratory, randomised, placebo-controlled trial

enthalten in: The Lancet. Respiratory medicine | 2022

von Ely, E. | Ramanan, A. | Kartman, C. | +25

CommentIn: Lancet Respir Med. 2022 Apr;10(4):314-315. - PMID 35123659

4

Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER) : a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial

enthalten in: The Lancet. Respiratory medicine | 2021

von Marconi, V. | Ramanan, A. | de Bono, S. | +105

CommentIn: Lancet Respir Med. 2021 Dec;9(12):1349-1351. - PMID 34480862

5

Subcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritis

enthalten in: Rheumatology (Oxford, England) | 2021

von Ruperto, N. | Brunner, H. | Ramanan, A. | +25

6

Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC) : an open-label, multicentre, randomised, controlled, phase 3 trial

enthalten in: The Lancet. Respiratory medicine | 2021

von Soin, A. | Kumar, K. | Choudhary, N. | +17

7

Adalimumab in Juvenile Idiopathic Arthritis-Associated Uveitis : 5-Year Follow-up of the Bristol Participants of the SYCAMORE Trial

enthalten in: American journal of ophthalmology | 2019

von Horton, S. | Jones, A. | Guly, C. | +5

8

Adalimumab in combination with methotrexate for refractory uveitis associated with juvenile idiopathic arthritis : a RCT

enthalten in: Health technology assessment (Winchester, England) | 2019

von Ramanan, A. | Dick, A. | Jones, A. | +16

9

Cost-Effectiveness Analysis of Adalimumab for the Treatment of Uveitis Associated with Juvenile Idiopathic Arthritis

enthalten in: Ophthalmology | 2019

von Hughes, D. | Culeddu, G. | Plumpton, C. | +11

CommentIn: Ophthalmology. 2019 Mar;126(3):425-427. - PMID 30803516

10

Canakinumab in patients with systemic juvenile idiopathic arthritis and active systemic features : results from the 5-year long-term extension of the phase III pivotal trials

enthalten in: Annals of the rheumatic diseases | 2018

von Ruperto, N. | Brunner, H. | Quartier, P. | +23